Page 85 - Sohini Das

Serum prices Covishield at Rs 400 for Centre, Rs 600 for private hospitals

These are the prices for institutional sales, and not the maximum retail price, which will be announced later.

Cadila Healthcare testing two-shot regimen for ZyCoV-D, data likely by May

The company is conducting phase 3 efficacy trials on a three-dose regimen of its DNA plasmid technology-based Covid-19 vaccine, which is in its last leg

Covaxin neutralises the double-mutant coronavirus strain, says ICMR

The B.1.617 or 'double mutant' Indian variant carries two mutations, including the L452R and E484Q

Covaxin shows 100% efficacy against 'severe Covid-19', 78% overall

The Bharat Biotech candidate has also shown 70 per cent efficacy against asymptomatic infections, suggesting that it prevents transmission

Coronavirus vaccine shot may cost Rs 1,000 in private market: Sources

Could be priced at Rs 600-650/dose for institutional sales

Prioritise country first, PM Modi tells Covid-19 vaccine makers

"He has asked the industry to prioritise deliveries to meet the country's needs first and then focus on global supplies," said a person in the know, who did not wish to be named.

Manufacturers look to boost capacity as govt enhances vaccination scope

Firms work to secure raw material locally as imports remain a challenge

Serum, Bharat Biotech to get suppliers' credit for 300 mn Covid-19 doses

Govt okays Rs 4,500 cr upfront payment for 300 mn doses

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Covid-19: Remdesivir output to be doubled to 7.4 mn doses by April-end

18 new sites get DCGI consent to make antiviral used for treating Covid-19

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Adar Poonawalla urges US Prez to lift ban on export of vaccine raw material

Poonawalla had said earlier that US curbs were hampering scale-up of Novavax vaccine at Pune. Serum has collaborated with Novavax of US to make its vaccine here and supply to Covax at $3 a shot

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Covid-19 vaccination: Too early to say if booster dose needed, say experts

Pfizer CEO has said a 3rd booster shot likely within a year of vaccination

Behind India's ventilator crisis: Lack of trained staff and idle units

Oxygen makers flag concern over shortage of liquid oxygen

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products

The second wave: Covid-19 testing labs look at ways to ramp up capacity

Now demand is growing almost 100 per cent week-on-week, leading to a testing crisis, said an industry insider.

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Bharat Biotech is trying to ramp up capacities of Covaxin to 12 million doses per month by July, from the current 5 million doses per month

Clinical trials on India's first mRNA Covid-19 vaccine to begin soon

Gennova's Covid vaccine candidate HGCO19 would remain stable at 2 to 8 degree Celsius temperature